Clincosm LogoSign in Get a demo

als

Showing 1 - 25 of 73
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adhd, ALS, Bronchial Asthma Trial in Bosisio Parini, Casatenovo, Milan (Prebiotic fiber, Dietary fiber, Probiotic)

Completed
  • Adhd
  • +2 more
  • Prebiotic fiber
  • +2 more
  • Bosisio Parini, LC, Italy
  • +3 more
Aug 21, 2023

ALS, PLS, MND (Motor Neurone DIsease) Trial in Italy, United States

Recruiting
  • ALS
  • +5 more
    • Gainesville, Florida
    • +8 more
    Jul 20, 2023

    ALS, Respiratory Insufficiency, Dysphagia Trial in Fort Lauderdale (Respiratory Muscle Strength Training (LVR+EMST))

    Not yet recruiting
    • ALS
    • +2 more
    • Respiratory Muscle Strength Training (LVR+EMST)
    • Fort Lauderdale, Florida
      Nova Southeastern University
    Jun 13, 2023

    ALS, FTD Trial in Worldwide (WVE-004, Placebo)

    Active, not recruiting
    • ALS
    • FTD
    • North Ryde, New South Wales, Australia
    • +16 more
    Feb 2, 2023

    ALS, Amyotrophic Lateral Sclerosis Trial in Canada, United States (ABBV-CLS-7262, Placebo)

    Active, not recruiting
    • ALS
    • Amyotrophic Lateral Sclerosis
    • Irvine, California
    • +13 more
    Jan 20, 2023

    ALS Trial in Japan (MT-1186)

    Recruiting
    • ALS
    • Chiba-shi, Chiba, Japan
    • +6 more
    Jan 15, 2023

    ALS, FTD Trial in Utrecht (WVE-004)

    Enrolling by invitation
    • ALS
    • FTD
    • Utrecht, Netherlands
      Universitair Medisch Centrum Utrecht
    Jan 4, 2023

    ALS Trial ([11C]CPPC PET ligand)

    Not yet recruiting
    • ALS
    • [11C]CPPC PET ligand
    • (no location specified)
    Jan 9, 2023

    Amyotrophic Lateral Sclerosis, ALS Trial in Worldwide (Placebo, Ravulizumab)

    Terminated
    Has Results
    • Amyotrophic Lateral Sclerosis
    • ALS
    • Placebo
    • Ravulizumab
    • Phoenix, Arizona
    • +94 more
    Dec 15, 2022

    ALS Trial in Worldwide (MT-1186, Placebo)

    Recruiting
    • ALS
    • Phoenix, Arizona
    • +94 more
    Dec 9, 2022

    A Single-Site Tissue Repository Providing Annotated Biospecimens

    Recruiting
    • Age-Related Macular Degeneration
    • +46 more
    • Specimen sample
    • Waltham, Massachusetts
      Sanguine Biosciences
    Nov 22, 2022

    Neurologic Disorders, Nervous System Diseases, Neurodegenerative Diseases Trial in Westport, Coral Springs, Dubai (Intravenous

    Recruiting
    • Neurologic Disorders
    • +25 more
    • Intravenous and Intranasal BMSC
    • Westport, Connecticut
    • +2 more
    Nov 25, 2022

    Amyotrophic Lateral Sclerosis, ALS Trial in Tel Aviv (PrimeC, Placebo)

    Recruiting
    • Amyotrophic Lateral Sclerosis
    • ALS
    • Loma Linda, California
    • +2 more
    Nov 23, 2022

    ALS, Charcot Disease Trial in Grenoble, Montpellier (Teleconsultation assisted by a physiotherapist or nurse)

    Not yet recruiting
    • ALS
    • Charcot Disease
    • Teleconsultation assisted by a physiotherapist or nurse
    • Grenoble, France
    • +1 more
    Nov 16, 2022

    ALS Trial in New York (Mag Stim)

    Terminated
    • ALS
    • Mag Stim
    • New York, New York
      Shara Holzberg
    Nov 9, 2022

    Factors Associated With Success of NIPPV in ALS Patients

    Active, not recruiting
    • ALS
      • Seongnam-si, Korea, Republic of
        Seoul National University Bundang Hospital
      Oct 30, 2022

      ALS, Amyotrophic Lateral Sclerosis Trial in Scottsdale, Jacksonville, Rochester (Autologous Adipose-derived Mesenchymal Stromal

      Active, not recruiting
      • ALS
      • Amyotrophic Lateral Sclerosis
      • Autologous Adipose-derived Mesenchymal Stromal Cells
      • Scottsdale, Arizona
      • +2 more
      Oct 10, 2022

      Genomic Translation for Amyotrophic Lateral Sclerosis Care

      Completed
      • ALS
        • Los Angeles, California
        • +13 more
        Aug 18, 2022

        Amyotrophic Lateral Sclerosis, ALS Trial in France, Italy (IFB-088 50mg/day, Placebo, Riluzole 100mg/day)

        Not yet recruiting
        • Amyotrophic Lateral Sclerosis
        • ALS
        • IFB-088 50mg/day
        • +2 more
        • Angers, France
        • +19 more
        Aug 18, 2022

        Amyotrophic Lateral Sclerosis, ALS Trial in Iowa City, Baltimore, Boston (LAM-002A, Placebo)

        Active, not recruiting
        • Amyotrophic Lateral Sclerosis
        • ALS
        • Iowa City, Iowa
        • +2 more
        Aug 10, 2022

        ALS, SCI - Spinal Cord Injury, Stroke Trial in San Francisco (PMT/Blackrock Combination Device)

        Recruiting
        • ALS
        • +4 more
        • PMT/Blackrock Combination Device
        • San Francisco, California
          University of California San Francisco
        Jul 29, 2022

        ALS Trial in Hershey (remote pulmonary function testing, standard pulmonary function testing, Nurse Respiratory Health Coaching

        Recruiting
        • ALS
        • remote pulmonary function testing
        • +2 more
        • Hershey, Pennsylvania
          Hershey Medical Center ALS Clinic
        Jul 12, 2022

        ALS Trial in Gainesville (Consume 20mg of istradefylline, Low Oxygen therapy, Placebo counterpart to the istradefylline drug)

        Recruiting
        • ALS
        • Consume 20mg of istradefylline
        • +3 more
        • Gainesville, Florida
          Clinical and Translational Research Building
        Jul 5, 2022

        Analyzing Participation Experiences Of Amyotrophic Lateral

        Not yet recruiting
        • ALS
        • Amyotrophic Lateral Sclerosis
          • (no location specified)
          Jun 14, 2022

          ALS Trial in Philadelphia ([11C]-PBR28)

          Terminated
          • ALS
          • Philadelphia, Pennsylvania
            University of Pennsylvania
          Apr 4, 2022